课题基金 / 基金详情

Determining the efficacy of capacitive deionization for the concentration of chemical and biological contaminants from water

Determining the efficacy of capacitive deionization for the concentration of chemical and biological contaminants from water
确定电容去离子对水中化学和生物污染物浓度的功效
批准号:
452677-2013
负责人:
Hall, JChristopher
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Engage Grants Program
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-01-01 至 2014-12-31

项目摘要

项目成果

Hall, JChristopher的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ENPAR Technologies uses state-of-the-art electrochemical technology, known as capacitive deionization, to effectively reduce the concentration of total dissolved solids in water. These include arsenic, nitrate, fluoride, sulfates, metals and other ionic compounds. The advantages of this system are its high removal efficiencies, high water recovery, low maintenance and energy costs. A novel application of this technology is to utilize the reject stream to detect chemical and biological pollutants present in low, but biologically significant, concentrations in water. This could improve the detection of diverse contaminants over current methods. This new University of Guelph/ENPAR collaboration aims to determine if the ENPAR ESD technology can remove two surrogate contaminants, the pesticide 2,4 D and the bacteriophage MS2 from different water sources representing chemical and biological contaminants, respectively. The development of a generalized method to concentrate chemical and biological contaminants from water would have industrial and regulatory importance. Successful implementation of the systems will contribute to Ontario's reputation as a leader in water treatment technologies and improve on Canada's position as an exporter of clean technologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Recombinant Antibody Technology
  • 批准号:
    1000210202-2008
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $14.57万
  • 财政年份:
    2013
  • 负责人:
    Hall, JChristopher
  • 依托单位:
Antibody-based bacterial cytotoxicity mediated by mechanisms independent of CDC and ADCC
  • 批准号:
    2243-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.08万
  • 财政年份:
    2013
  • 负责人:
    Hall, JChristopher
  • 依托单位:
Recombinant Antibody Technology
  • 批准号:
    1000210202-2008
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $14.57万
  • 财政年份:
    2012
  • 负责人:
    Hall, JChristopher
  • 依托单位:
Antibody-based bacterial cytotoxicity mediated by mechanisms independent of CDC and ADCC
  • 批准号:
    2243-2009
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.08万
  • 财政年份:
    2012
  • 负责人:
    Hall, JChristopher
  • 依托单位:
国内基金
海外基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    肖勤
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: